Methapharm Report issue

For profit Phase 2
Founded: Coral Springs FL United States (1996)
Status: No NME R&D (1996)

Organization Overview

First Clinical Trial
2012
NCT01429181
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2012

Timeline

NOW
  • Now

Alternative names

METHAPHARM | MethaPharm, Inc.

Active Ingredients

Marketed Drugs (1)

methacholine (provocholine) (1986)

Drugs in Phase 2 Trials (1)

methadone (methadose) (1 trial)

Indications

Experimental Indications (Clinical Trials, Phases 1-4)


 

Neuralgia (Phase 2)

Overview

  • Highest Phase: Phase 2
  • # of Trials: 1
  • # of Trial APIs: 1